Increasing Trends in Nonfatal Fentanyl Overdose Emergency Visits Through Q3 2023
Recent CDC research reveals a significant increase in nonfatal fentanyl overdose ED visits through the third quarter of 2023, highlighting ongoing public health concerns and the need for targeted interventions.
Recent research indicates a concerning rise in nonfatal overdose emergency department visits related to fentanyl, continuing through the third quarter of 2023. Data compiled from the CDC’s Morbidity and Mortality Weekly Report shows an 8.7% quarterly increase in these incidents between late 2020 and late 2023, with rates climbing from 1.4 to 3.5 per 10,000 ED visits. Notably, the increase was most prominent among non-Hispanic American Indian or Alaska Native populations, who experienced the highest rates and the greatest growth, with an average quarterly increase of 9.0%. However, from Q3 2023 onward, there was an 11.0% quarterly decline, bringing the rate down to 2.9 per 10,000 visits by the first quarter of 2024.
Researchers, led by Cassandra M. Pickens, Ph.D., analyzed trends across various demographics such as age, sex, race, and ethnicity to understand the scope of fentanyl's impact. Their findings highlight the importance of ongoing local and state monitoring to identify areas requiring targeted prevention, treatment, and recovery programs. The rise in nonfatal overdoses underscores the ongoing challenge of fentanyl exposure and the critical need for enhanced public health interventions.
This data emphasizes the persistent and evolving crisis posed by fentanyl, urging health authorities and communities to remain vigilant and proactive in combating this public health issue.
source: https://medicalxpress.com/news/2025-05-fentanyl-nonfatal-overdose-ed-rose.html
Stay Updated with Mia's Feed
Get the latest health & wellness insights delivered straight to your inbox.
Related Articles
Key Mechanism Identified That Shields SARS-CoV-2 During Replication
Researchers have identified a vital mechanism that SARS-CoV-2 uses to protect its spike protein during replication, offering new targets for antiviral therapies and vaccine development.
New Insights into the Enzymatic Mechanisms Behind Rare Metabolic Disorder
A groundbreaking study uncovers how a specific mutation in the enzyme cystathionine beta-synthase disrupts its function in rare metabolic disorder, opening new avenues for tailored treatments.
Risks of Misinformation on TikTok Concerning Birth Control Discovered
A study reveals that misleading birth control information on TikTok could lead to unsafe choices and unplanned pregnancies among young women. Experts call for credible health messaging to counteract misinformation advertising.
Limited Access to Vaginal Birth After C-Section in U.S. Counties
Research shows that only 16% of U.S. counties offer access to vaginal birth after cesarean, highlighting significant regional disparities and barriers in maternal care.